<DOC>
	<DOCNO>NCT01880073</DOCNO>
	<brief_summary>A thorough infertility evaluation commonly involve determine whether woman 's fallopian tubes patent . The two often utilized method evaluate fallopian tube hysterosalpingogram ( take X-ray pelvis inject dye uterus fallopian tube ) laparoscopic chromopertubation ( surgical procedure dye visualize pass fallopian tube ) . The FemVue Saline-Air device new method assess tubal patency . The device utilizes mixture saline air bubble see pass fallopian tube ultrasound . FemVue efficiently perform physician 's office minimally invasive . Unlike hysterosalpingogram laparoscopic chromopertubation , carry risk anesthesia surgery , n't expose patient radiation contrast . It , like two method , carry small risk infection . This study involve use FemVue device patient anesthesia operate room undergo schedule laparoscopic chromopertubation , gold standard evaluate tubal patency . The two method compare determine accuracy FemVue device .</brief_summary>
	<brief_title>FemVue Tubal Patency</brief_title>
	<detailed_description>Subjects agree participate tube evaluate use FemVue Saline-Air device laparoscopic chromopertubation .</detailed_description>
	<criteria>Pts age 1845 undergoing plan diagnostic laparoscopy chromopertubation . Adnexal mass &gt; 3.5cm uterine size great 10 wks</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>